Skip to main content
    S

    Shattuck Labs Inc (STTK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.66
    +0.01 (+0.22%)

    Market Cap: $473.57M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Shattuck Labs Inc (STTK) Financials: Revenue, Profit and Cash Flow

    Updated Nov 5, 2026. Financial statements from company filings, amounts in US dollars.

    Shattuck Labs reported revenue of $1.00M for the fiscal year ended Dec 31, 2025, down 82.5% from the year before. That year, net income was -$48.81M with a net margin of -4880.9%, operating cash flow was -$39.88M and free cash flow was -$39.95M. The quarter ended Sep 30, 2026 had revenue of $0 and net income of -$25.20M.

    Revenue and Margins

    Over the 7 years to Dec 2025, revenue fell from $22.44M, a compound annual decline of 35.9%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$1.00M-82.5%100.0%-5150.8%-4880.9%
    Dec 2024$5.72M+245.3%100.0%-1408.3%-1318.1%
    Dec 2023$1.66M+154.1%100.0%-5549.6%-5268.4%
    Dec 2022$652.00K-97.8%100.0%-15848.0%-15635.7%
    Dec 2021$30.02M+202.2%100.0%-150.8%-149.8%
    Dec 2020$9.93M+0.5%100.0%-371.8%-368.5%
    Dec 2019$9.89M-55.9%100.0%-253.5%-242.6%
    Dec 2018$22.44MN/A-10.5%-27.4%-32.9%
    Annual, fiscal years ended Dec 2018 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Revenue$1.00M$5.72M$1.66M$652.00K$30.02M$9.93M$9.89M$22.44M
    Cost of revenue$0$0$0$0$0$0$0$24.81M
    Gross profit$1.00M$5.72M$1.66M$652.00K$30.02M$9.93M$9.89M-$2.37M
    Research and development$35.27M$67.21M$74.31M$82.90M$56.56M$37.48M$29.22M$24.81M
    Operating income-$51.51M-$80.57M-$91.96M-$103.33M-$45.27M-$36.93M-$25.07M-$6.15M
    Net income-$48.81M-$75.41M-$87.30M-$101.94M-$44.97M-$36.60M-$23.98M-$7.39M
    EBITDA-$48.28M-$78.91M-$89.41M-$99.09M-$41.18M-$36.53M-$24.63M-$4.50M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$0$0$0$0$1.00M$0$0$34.70M$3.00M$1.61M$1.11M$714.00K
    Gross profit$0$0$0-$906.00K$1.00M$0$0$14.49M$3.00M$1.61M$1.11M$714.00K
    Operating income-$27.05M-$16.16M-$15.54M-$13.37M-$10.72M-$13.03M-$14.39M-$19.64M-$17.92M-$22.96M-$20.04M-$18.95M
    Net income-$25.20M-$15.15M-$14.77M-$12.59M-$10.06M-$12.46M-$13.70M-$18.68M-$16.68M-$21.55M-$18.50M-$17.69M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of $837.00K by $53.35M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Total assets$91.03M$91.05M$159.56M$205.32M$298.58M$348.99M$44.97M$68.16M
    Current assets$82.47M$79.22M$143.22M$184.58M$288.27M$345.64M$42.44M$65.63M
    Cash and equivalents$54.19M$57.39M$125.63M$47.38M$92.27M$157.90M$7.01M$31.64M
    Total liabilities$8.64M$11.42M$14.86M$29.17M$26.80M$39.13M$30.45M$79.24M
    Short-term debt$837.00K$900.00K$796.00K$701.00KN/A$6.93M$3.61M$1.73M
    Shareholder equity$82.39M$79.63M$144.71M$176.16M$271.79M$309.86M-$34.55M-$11.08M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$207.97M$220.67M$102.12M$91.03M$100.33M$64.37M$77.17M$91.05M$111.72M$128.61M$146.34M$159.56M
    Total liabilities$14.31M$9.53M$6.29M$8.64M$7.09M$7.35M$9.58M$11.42M$15.14M$18.00M$17.52M$14.86M
    Cash and equivalents$61.76M$63.30M$90.42M$54.19M$42.55M$50.47M$60.90M$57.39M$43.83M$60.69M$76.00M$125.63M
    Shareholder equity$193.66M$211.14M$95.83M$82.39M$93.24M$57.02M$67.59M$79.63M$96.58M$110.62M$128.81M$144.71M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow-$39.88M-$60.52M-$81.23M-$94.50M-$57.12M-$33.66M-$20.98M-$6.90M
    Capital expenditures$71.00K$59.00K$407.00K$11.61M$7.93M$727.00K$470.00K$1.18M
    Free cash flow-$39.95M-$60.57M-$81.64M-$106.11M-$65.04M-$34.39M-$21.45M-$8.08M
    Share repurchases$0$17.00KN/AN/AN/A$19.28M$64.00KN/A
    Investing cash flow-$7.89M-$8.51M$110.86M$49.44M-$10.44M-$146.32M-$3.59M-$29.93M
    Financing cash flow$44.57M$787.00K$48.62M$171.00K$1.93M$330.87M-$64.00K$35.15M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$17.47M-$10.19M-$13.42M-$8.49M-$8.93M-$10.43M-$12.03M-$17.37M-$16.07M-$10.92M-$16.16M-$19.42M
    Capital expenditures$50.00KN/A$63.00K$0$71.00K$10.43M$0$0$42.00K$17.00K$0$17.00K
    Free cash flow-$17.52MN/A-$13.49M-$8.49M-$9.00M-$20.86M-$12.03M-$17.37M-$16.11M-$10.94M-$16.16M-$19.44M
    Last 12 quarters

    Frequently Asked Questions About STTK

    What is Shattuck Labs' annual revenue?

    Shattuck Labs reported revenue of $1.00M for the fiscal year ended Dec 31, 2025.

    How fast is Shattuck Labs' revenue growing?

    Revenue was down 82.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 15.3%.

    Is Shattuck Labs profitable?

    No. Shattuck Labs reported net income of -$48.81M for the fiscal year ended Dec 31, 2025, with a net margin of -4880.9%.

    How much free cash flow does STTK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$39.88M minus capital expenditures of $71.00K produced free cash flow of -$39.95M.

    How much debt does Shattuck Labs have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of $837.00K and cash and equivalents of $54.19M.